Bioxyne Ltd : Confirmation of Release - BXN - Completion of placement follow up

Suite 1001, 4 Bridge St

Sydney NSW 2000

P: [phone]

E: [e-mail]
W: www.bioxyne.com

Australian Securities Exchange Companies Announcements Office Exchange Centre
Level 6
20 Bridge Street
Sydney, NSW 2000
20 February 2013 Bioxyne completes Share Placement to raise up to $508,000 ("Placement")

Further to the earlier announcement of the completion of the Placement, Bioxyne Limited (BXN or the Company) advises that Phillip Asset Management Limited ("PAM"), a major shareholder of the Company participated as a sub-underwriter to the Placement.
PAM subscribed for 12,600,000 shares at the book build price of 2.2 cents plus a 1 for 2 attaching option ("Option"), exercisable at 4 cents, with an expiry date of 31 March 2015. The Option is subject to shareholders approval, which is expected to take place with the approval of the acquisition of VITALITY Devices Pty Limited.
The amount invested by PAM of $277,200 is scheduled for settlement on 25 February 2013.
The 12,600,000 shares subscribed for by PAM represented 55% of the Placement. On allotment of the placed shares, PAM's relevant interest in the capital of BXN would increase from the current shareholding of 20.35% to 24.81%.

For more information, contact Jarrod White Chief Financial Officer Mobile: [phone]

1